In this JAMA Health Forum column, KFF’s Larry Levitt examines the criticism that health insurance companies are facing from political leaders, and explores the industry’s role in both causing and addressing some of the health systems’ biggest problems, including rising costs and prior authorization review.
Recent Posts
- Distinguished Programs expands into reinsurance market with new Antares Re-backed platform
- Hyperscale data centres a growing but increasingly selective opportunity for re/insurers: S&P
- Lumos Insurance adds Kenny as MD & SVP, Global Retirement and Protection
- US flood landscape a strategic opportunity for incumbents and disruptors alike: Vardigans, Fathom
- Pacific Life Re completes third asset-intensive block reinsurance deal with Anshin Life




